Kobo Biotech has informed that the Board of Directors of the company at their meeting held today on Thursday, 11th August, 2022 approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2022 along with the Limited review report of statutory auditor thereon. The company has enclosed a copy of the unaudited Financials along with Limited Review report from the Statutory Auditors. The above-referred meeting was commenced at 1.00 pm and concluded at 2:00 pm. The above is pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, for the information and record.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: